Ozempic (semaglutide)
Ozempic is a once-weekly Semaglutide injection licensed for type-2 diabetes.
Description
Semaglutide (Ozempic) is a prescription medication used to treat and manage Type 2 Diabetes. The active ingredient is Semaglutide which mimics the action of one of your bodies natural hormones (GLP1).
It is also responsible for making you feel full and as a result, reducing your appetite. GLP1/Semaglutide also delays the emptying of your stomach which again goes toward making you feel fuller for longer.
Semaglutide (Ozempic) and weight loss
Whilst Ozempic has been marketed and licensed for Diabetes, the active ingredient (Semaglutide) has shown to suppress appetite and help the person taking it feel fuller quicker after a meal and for longer. This means that those taking Semaglutide are not just likely to consume less during a meal, feeling fuller for longer would mean being less likely to snack as much between meals. This reduction in appetite may also contribute to patients eating smaller portions than what they’re used to. An overall significantly less calorie deficit would tend to result in patients beginning to lose weight when they start taking Ozempic.
Technical Data
| The beginning dose is 0.25 mg once a week for the first 4 weeks. This will give your body a chance to get used to the medicine. At Week 5, you will increase the dose to 0.5 mg once a week, followed by 1.0mg. Once you have reached 1.0mg you remain on that for the duration of your treatment. |
|---|
